Obstetrics and Gynecology Patients: Menstrual Cycle, Pregnancy, and Postpartum-Related Psychiatric Disorders

  • Beena Nair

A 40-year-old woman who is 15 weeks pregnant and has gestational diabetes was referred for psychiatric evaluation for increasing anxiety and depression. During the psychiatric interview the patient reported feeling very depressed, anxious, restless, confused, and somewhat agitated for the last several weeks, worried that something bad was going to happen to her fetus and her three older children. She also reported racing thoughts, palpitation, feeling very hot and sweaty, and weight loss. The patient denied any past psychiatric history or treatment and denied any alcohol or illicit substance use. On further workup, the patient had a thyroid-stimulating hormone (TSH) of <0.004. She was diagnosed with thyrotoxicosis, and treatment started with propylthiouracil. The patient was also started on an antidepressant and a low dose of antipsychotic to control her agitation.


Bipolar Disorder Psychotropic Medication Edinburgh Postnatal Depression Scale Mood Stabilizer Postpartum Depression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ahoka A, Kaukoranta J, et al. Estrogen deficiency in severe PPD: Successful treatment with sublingual physiologic 17 beta estradiol: a preliminary study. J Clin Psych 2001;62:5.Google Scholar
  2. Altshuler LL, Cohen L, Szuba MP, et al. Pharmacologic management of psychiatric illness in pregnancy: dilemmas and guidelines. Am J Psychiatry 1996;153:592–606.PubMedGoogle Scholar
  3. Appleby L. Suicide during pregnancy and in the first postnatal year. Br Med J 1991;302:137–140.CrossRefGoogle Scholar
  4. Arnold LM, Gender differences on bipolar disorder. Psychiatry Clin North Am. 2003 Sep;26(3):595–620.CrossRefGoogle Scholar
  5. Bailara KM, et al. Decreased brain tryptophan availability as a partial determinant of postpartum blues. Psychoneuroendocrinology 2005;31(3):407–413; Epub November 21, 2005.PubMedCrossRefGoogle Scholar
  6. Brinsmead M, Smith R, Singh B, Lewin T, Owens P. Peripartum concentrations of beta endorphin and cortisol and maternal mood states. Aust NZ J Obstet Gynaecol 1985;25(3):194–197.CrossRefGoogle Scholar
  7. Chambers C, Johnson K, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010–1015.PubMedCrossRefGoogle Scholar
  8. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. New Engl J Med 2006;354:579–587.PubMedCrossRefGoogle Scholar
  9. Chaudron L, Pies R. The relationship between postpartum psychosis and bipolar disorder: a review. J Clin Psychiatry 2003;64:1284–1292.PubMedGoogle Scholar
  10. Cicchetti D, Rogosch F, Toth S. Maternal depressive disorder and contextual risk: contributions to the development of attachment insecurity and behavior problems in toddlerhood. Dev Psychopathol 1998;10:283–300.PubMedCrossRefGoogle Scholar
  11. Cohen L, Nonacs RM, et al. Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Arch Womens Mental Health 2004;7;217–221.CrossRefGoogle Scholar
  12. Cohen L, Sichel D, Robertson L, et al. Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry 1995;152:1641–1645.PubMedGoogle Scholar
  13. Cooper P, Murray L. Course and recurrence of postnatal depression. Br J Psychiatry 1995;166:191–195.PubMedCrossRefGoogle Scholar
  14. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression: development of the 10–item Edinburgh Postnatal Depression scale. Br J Psychiatry 1987;150:782–786.PubMedCrossRefGoogle Scholar
  15. Dennis C. The effect of peer support on PPD: A pilot randomized controlled trial. Can J Psychiatry 2003;48(2):115–124.PubMedGoogle Scholar
  16. Ebbesen F, Joergensen A, et al. Neonatal hypoglycemia and withdrawal symptoms after exposure in utero to valproate. Arch Dis Child (Fetal Neonate Ed) 2000;83:F124–F129.CrossRefGoogle Scholar
  17. Einarson A, Bonari L, et al. A multicentre prospective controlled study to determine the safety of trazadone and nafazadone use during pregnancy. Can J Psychiatry 2003;48:106–110.PubMedGoogle Scholar
  18. Einarson A, Fatoye B, et al. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 2001;158:1728–1730.PubMedCrossRefGoogle Scholar
  19. Epperson N, Czarkowski K, et al. Maternal sertraline treatment and serotonin transport in breast feeding mother-infant pairs. Am J Psychiatry 2001;158:1631–1637.PubMedCrossRefGoogle Scholar
  20. Essex M, Klein M, et al. Maternal stress beginning in infancy may sensitize children to later stress exposure: effects on cortisol and behavior. Biol Psychiatry 2002;52:776–784.PubMedCrossRefGoogle Scholar
  21. Gardiner S, Kristensen J, et al. Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast fed infants. Am J Psychiatry 2003;160:1428–1431.PubMedCrossRefGoogle Scholar
  22. Gotlib I, et al. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 1989;57(2):269–274.PubMedCrossRefGoogle Scholar
  23. Gregoire AJP, Kumar R. Transdermal estrogen for treatment of severe postpartum depression. Lancet 1996;347:930–933.PubMedCrossRefGoogle Scholar
  24. Hale T, Shum S, Grossberg M. Fluoxetine toxicity in a breastfed infant. Clin Pediatr 2001;40:681–684.CrossRefGoogle Scholar
  25. Harris B, Othman S, Davies JA, et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. Br Med J 1992;305(6846):152–156.CrossRefGoogle Scholar
  26. Hendrick V, Smith L, et al. Weight gain in breastfed infants of mothers taking antidepressant medication. J Clin Psychiatry 2003;64:410–412.PubMedGoogle Scholar
  27. Hendrick V, et al. Postpartum and nonpostpartum depression: Differences in presentation and response to pharmacologic treatment. Depression Anxiety 2000;11:66–72.CrossRefGoogle Scholar
  28. Heikkinen, et al. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002;72(2):184–191.PubMedCrossRefGoogle Scholar
  29. Henshaw C, Foreman D, Cox J. Postnatal blues: a risk factor for postnatal depression. J Psychosom Obstet Gynecol 2004;25:267–272.CrossRefGoogle Scholar
  30. Heron J, O’Connor T, et al. The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disord 2004;80:65–73.PubMedCrossRefGoogle Scholar
  31. Jager-Roman E, Deichi A, et al. Fetal growth, major malformations and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986;108:997–1004.PubMedCrossRefGoogle Scholar
  32. Jones KL, Lacro R, et al. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989;320:1661–1666.PubMedCrossRefGoogle Scholar
  33. Lawrie T, Hofmeyr GJ, Jager M, et al. A double blind randomized placebo controlled trial of postnatal northisterone enanthate: the effect on postnatal depression and serum hormones. Br J Obstet Gynaecol 1998;105:1082–1090.PubMedGoogle Scholar
  34. Lee DTS, Wong CK, et al. Screening psychiatric morbidity after miscarriage: application of the 30–item GHQ and EPDS. Psychosom Med 1997;59:207–210.PubMedGoogle Scholar
  35. Marzuk P, Tardiff D, et al. Lower risk of suicide during pregnancy. Am J Psychiatry 1997;154:122–123.PubMedGoogle Scholar
  36. McElhatton P. The effects of Benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994;8(6):461–475.PubMedCrossRefGoogle Scholar
  37. Mckenna K, Koren G, Tetelbaum M, et al. Pregnancy outcome of women using atypical antipsychotic drugs: A prospective comparative study. J Clin Psychiatry 2005;66:444–449.PubMedCrossRefGoogle Scholar
  38. Miller L. Use of electroconvulsive therapy during pregnancy. Hosp Commun Psychiatry 1994;45(5):444–450.Google Scholar
  39. Nulman I, Rovet J. Child development following exposure to TCA or fluoxetine throughout fetal life: a prospective controlled study. Am J Psychiatry 2002;159:1889–1895.PubMedCrossRefGoogle Scholar
  40. Nulman I, Rovet J, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258–262.PubMedCrossRefGoogle Scholar
  41. O’Connors T, et al. Maternal antenatal anxiety and behavioral/emotional problems in children: a test of a programming hypothesis. J Child Psychol Psychiatry 2003;44(7):1025–1036.CrossRefGoogle Scholar
  42. O’Hara M, Schelchte J, Lewis D. Prospective study of postpartum blues, biologic and psychosocial factors. Arch Gen Psychiatry 1991;48:801–806.PubMedGoogle Scholar
  43. O’Hara M, Stuart S, Gorman L, Wenzel A. Efficacy of Interpersonal psychotherapy for postpartum depression. Arch Gen Psychiatry 2000;57:1039–1045.PubMedCrossRefGoogle Scholar
  44. Robling SA, Paykel ES, et al. Long term outcome of severe puerperal psychiatric illness: a 23 year follow up study. Psychol Med 2000;30:1263–1271.PubMedCrossRefGoogle Scholar
  45. Roy-Byrne P, Dager S, et al. Relapse and rebound following discontinuation of benzo treatment of panic attacks: Alprazolam versus Diazepam. Am J Psychiatry 1989;146;7:860–865.PubMedGoogle Scholar
  46. Safra M, Oakley G. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 1975 Sept 13;478–480.CrossRefGoogle Scholar
  47. Schimidt P et al. A longitudinal evaluation of the relationship between reproductive status and mood in perimenupausal women. Am J Psych 2004;161:2238–2244.CrossRefGoogle Scholar
  48. Schou M. What happened later to the lithium babies? A follow-up study of children born without malformations. Acta Psychiatr Scand 1976;54(3):193–197.PubMedCrossRefGoogle Scholar
  49. Sherer D, D’Amico, et al. Recurrent mild abruption placentae occurring immediately after repeated ECT in pregnancy. Am J Obstet Gynecol 1991;165;652–653.PubMedGoogle Scholar
  50. Spinelli M. Interpersonal psychotherapy for depressed antepartum women: a pilot study. Am J Psychiatry 1997;154:1028–1030.PubMedGoogle Scholar
  51. Stewart DE. Prophylactic lithium in postpartum affective psychosis. J Nerv Mental Dis 1988;176(8):485–489.CrossRefGoogle Scholar
  52. Teixeira JM, et al. Association between maternal anxiety in pregnancy and increased uterine artery resistance index: a cohort study. Br Med J 1999;318(7193):1288–1289.Google Scholar
  53. Thisted E, Ebbesen F. Malformations, withdrawal manifestations and hypoglycemia after exposure to valproate in utero. Arch Dis Child 1993;69:288–291.PubMedCrossRefGoogle Scholar
  54. Viguera A, Nonacs R. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000;157:179–184.PubMedCrossRefGoogle Scholar
  55. Weinstock L, Cohen L, et al. Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series. Psychother Psychosom 2001;70:158–162.PubMedCrossRefGoogle Scholar
  56. Yoshida K, Smith B, et al. Fluoxetine in breast milk and developmental outcomes of breast-fed infants. Br J Psychiatry 1998;172:175–179.PubMedCrossRefGoogle Scholar
  57. Zeskind PS, Stephens L. Maternal SSRI use during pregnancy and newborn neurobehavior. Pediatrics 2004;113(2):368–375.PubMedCrossRefGoogle Scholar
  58. Zuckerman B, et al. Depressive symptoms during pregnancy: relationship to poor health behaviors. Am J Obstet Gynecol 1989;160:1107–1111.PubMedGoogle Scholar
  59. Zuckerman B, et al. Maternal depressive symptoms during pregnancy and newborn irritability. J Dev Behav Pediatr 1990;11:190–194.PubMedCrossRefGoogle Scholar


  1. Casper R, Fleisher B, et al. Follow up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 2003;142:402–408.PubMedCrossRefGoogle Scholar
  2. Chambers C, Anderson P, Thomas R, et al. Weight gain in infants breast fed by mothers who take fluoxetine; Pediatrics Nov 1999;104(5):1–5.CrossRefGoogle Scholar
  3. Chaudron L, Jefferson J. Mood stabilizers during breastfeeding: a review. J Clin Psychiatry 2000;61:79–90.PubMedGoogle Scholar
  4. Chaudron L, Szilagyi PG, Kitzman H, et al. Detection of postpartum depressive symptoms by screening at well-child visits. Pediatrics 2004;113(3):551–558.PubMedCrossRefGoogle Scholar
  5. Cohen L, Friedman JM, Jefferson J, et al. A reevaluation of risk of in utero exposure to lithium. JAMA 1994;271:146–150.PubMedCrossRefGoogle Scholar
  6. Cohen L, Heller V, et al. Birth outcomes following prenatal exposure to fluoxetine. Biol Psychiatry 2000;48:996–1000.PubMedCrossRefGoogle Scholar
  7. Cohen L, Nonacs R. Mood and Anxiety Disorders During Pregnancy and Postpartum. Washington, DC: American Psychiatric Press 2005.Google Scholar
  8. Edhborg M, Lundh W, et al. The parent-child relationship in the context of maternal depressive mood. Arch Womens Mental Health 2003;6:211–216.CrossRefGoogle Scholar
  9. Ernst C, Goldberg J. The reproductive safety profile of mood stabilizers, atypical antipsychotics and broad spectrum psychotropics. J Clin Psychiatry 2002;63(suppl 4):42–55.PubMedGoogle Scholar
  10. Llewellyn A, Stowe Z. Psychotropic medications in lactation. J Clin Psychiatry 1998:59(suppl 2):41–52.PubMedGoogle Scholar
  11. Llewellyn A, Stowe Z, Strader J. The use of lithium and management of women with bipolar disorder during pregnancy and lactation. J Clin Psychiatry 1998;59(suppl 6):57–64.PubMedGoogle Scholar
  12. Miller L. Postpartum Mood Disorder. Washington, DC: American Psychiatric Press 1999.Google Scholar
  13. O’Hara M. Social support, life events and depression during pregnancy and puerperium. Arch Gen Psychiatry 1986;43:569–573.PubMedGoogle Scholar
  14. Quinlan J, Hill A. Nausea and vomiting of pregnancy. Am Fam Physician 2003;68(1):121–128.Google Scholar
  15. Rapkin A. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendocrinology 2003;28:39–53.PubMedCrossRefGoogle Scholar
  16. Robertson E, Grace S, et al. Antenatal risk factors for postpartum depression: a synthesis of recent literature. General Hosp Psychiatry 2004;26:289–295.CrossRefGoogle Scholar
  17. Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord 2003;74:67–83.PubMedCrossRefGoogle Scholar
  18. Thapar AK, Thapar A. Psychological sequelae of miscarriage: a controlled study using general health questionnaire and the hospital anxiety and depression scale. Br J Gen Pract 1992;42(356):94–96.PubMedGoogle Scholar
  19. Wisner K, Perel J, Peindl K, et al. Prevention of postpartum depression: a pilot randomized controlled trial. Am J Psychiatry 2004;161:1290–1292.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Beena Nair
    • 1
  1. 1.University of CaliforniaSan FranciscoUSA

Personalised recommendations